Clinically relevant changes in sexual desire, satisfying sexual activity and personal distress as measured by the profile of female sexual function, sexual activity log, and personal distress scale in postmenopausal women with hypoactive sexual desire disorder

This randomized controlled trial evaluated the effectiveness of transdermal testosterone therapy (TTP) in postmenopausal women with hypoactive sexual desire disorder (HSDD), demonstrating significant improvements in sexual desire, satisfying sexual activity (SSA), and reductions in personal distress. The study identified clinically meaningful changes, with responder rates in the testosterone group being